Contribution of human recombinant Interferon-Alpha 2b treatment in symptomatic and asymptomatic patients with SARS-CoV-2 virus infection

Introduction: Subjects with asymptomatic infections are not generally admitted to health care facilities, however, they may benefit from antiviral therapy.Objective: To evaluate the contribution to treatment with combined therapy based on recombinant human interferon alpha 2b + Lopinavir/Ritonavir...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Revista Habanera de Ciencias Médicas
Principais autores:	Cristobal González-Losada, Anabel González Blanco, Luis Gabriel González-Lodeiro, Abraham Ismael Beato Canfux, Diana del-Barco-García, Gerardo Enrique Guillén Nieto
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Universidad de Ciencias Médicas de La Habana 2022
Assuntos:	Medicina
Acesso em linha:	https://www.redalyc.org/articulo.oa?id=180473699007 https://www.redalyc.org/journal/1804/180473699007/ https://www.redalyc.org/journal/1804/180473699007/html/ https://www.redalyc.org/journal/1804/180473699007/180473699007.epub https://www.redalyc.org/journal/1804/180473699007/movil
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!